Page last updated: 2024-08-21

quinazolines and Endometriosis

quinazolines has been researched along with Endometriosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jin, ZX; Liu, F; Liu, YX; Min, SY; Wang, L; Zhang, XX; Zhu, ZL; Zuo, Z	1
D'Cruz, OJ; Uckun, FM	1

Reviews

1 review(s) available for quinazolines and Endometriosis

Article	Year
Targeting mast cells in endometriosis with janus kinase 3 inhibitor, JANEX-1. American journal of reproductive immunology (New York, N.Y. : 1989), 2007, Volume: 58, Issue:2 Topics: Endometriosis; Female; Humans; Infertility, Female; Janus Kinase 3; Mast Cells; Quinazolines	2007

Other Studies

1 other study(ies) available for quinazolines and Endometriosis

Article	Year
Vascular endothelial growth factor receptor-2 inhibitor cediranib causes regression of endometriotic lesions in a rat model. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2 Topics: Animals; Cell Proliferation; Disease Models, Animal; Endometriosis; Female; Neovascularization, Pathologic; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor Receptor-2	2015

Article

Year

Vascular endothelial growth factor receptor-2 inhibitor cediranib causes regression of endometriotic lesions in a rat model.

International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:2

Topics: Animals; Cell Proliferation; Disease Models, Animal; Endometriosis; Female; Neovascularization, Pathologic; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor Receptor-2

2015